Zeo Scientifix Inc Revenue Growth Rates (BPSR), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Zeo Scientifix Inc   (BPSR)
 

BPSR's Revenue Growth by Quarter and Year

Zeo Scientifix Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BPSR Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter October -
3rd Quarter July -
2nd Quarter April 2.58
1st Quarter January 1.45
FY 4.03

BPSRs Annual Revenue
Zeo Scientifix Inc 's Revenue in the fiscal year 2024 $ 5.20 millions
Zeo Scientifix Inc 's Revenue in the fiscal year 2023 $ 4.56 millions
Zeo Scientifix Inc 's Revenue in the fiscal year 2022 $ 6.49 millions
Zeo Scientifix Inc 's Revenue in the fiscal year 2021 $ 5.60 millions
Zeo Scientifix Inc 's Revenue in the fiscal year 2020 $ 3.06 millions




BPSR Revenue second quarter 2026 Y/Y Growth Comment
Zeo Scientifix Inc achieved in the second quarter 2026, above Company average Revenue surge of 124.43% year on year, to $ 2.58 millions.

Looking into second quarter 2026 results within Biotechnology & Pharmaceuticals industry 36 other companies have achieved higher Revenue growth. While Zeo Scientifix Inc ' s Revenue doubling of 124.43% ranks overall at the positon no. 2300 in the second quarter 2026.


BPSR Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter October - 33.06 % -12.68 % -1.39 %
3rd Quarter July - 20.18 % -10.66 % -28.65 %
2nd Quarter April 124.43 % 1.77 % 32.94 % -51.15 %
1st Quarter January 33.03 % -5.22 % 7.48 % -33.13 %
FY   - 12.8 % 1.1 % -

Financial Statements
Zeo Scientifix Inc 's second quarter 2026 Revenue $ 2.58 millions BPSR's Income Statement
Zeo Scientifix Inc 's second quarter 2025 Revenue $ 1.15 millions Quarterly BPSR's Income Statement


BPSR Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter October - 25.95 % 13.76 % 16.39 %
3rd Quarter July - 13.91 % -3.54 % 43.53 %
2nd Quarter April 78 % 5.5 % -1.74 % -20.56 %
1st Quarter January -12.12 % -12.1 % -19.01 % -25.69 %
FY (Year on Year)   - 12.8 % 1.1 % -


Back to BPSR Growth rate Comparisons >> Back to BPSR Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #37
Healthcare Sector #331
Overall #2300

Revenue Y/Y Growth Statistics
High Average Low
935.55 % 93.32 % -44.44 %
(Jan 31 2018)   (Apr 30 2017)
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #37
Healthcare Sector #331
Overall #2300
Revenue Y/Y Growth Statistics
High Average Low
935.55 % 93.32 % -44.44 %
(Jan 31 2018)   (Apr 30 2017)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Zeo Scientifix Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
23832.48 % 527.69 % -80.72 %
(Apr 30 2017)  


BPSR's II. Quarter Q/Q Revenue Comment
Zeo Scientifix Inc achieved in the II. Quarter 2026 below company average Revenue jump of 78% quarter on quarter, to $ 2.58 millions.

Although the II. Quarter 2026 Revenue Q/Q growth was lower than the regular , this has been yet encouraging story, as the II. Quarter surge, eclipses the 5.5% growth in the II. Quarter a year ago

Within Biotechnology & Pharmaceuticals industry 7 other companies have achieved higher Revenue quarter on quarter growth. While Zeo Scientifix Inc 's Revenue growth quarter on quarter, overall rank is 158.


Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #8
Healthcare Sector #49
Overall #158
Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #8
Healthcare Sector #49
Overall #158
Revenue Q/Q Growth Statistics
High Average Low
23832.48 % 527.69 % -80.72 %
(Apr 30 2017)  


BPSR's II. Quarter Q/Q Revenue Comment
Zeo Scientifix Inc achieved in the II. Quarter 2026 below company average Revenue jump of 78% quarter on quarter, to $ 2.58 millions.

II. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the 5.5% in the II. Quarter a year ago.

Within Biotechnology & Pharmaceuticals industry 7 other companies have achieved higher Revenue quarter on quarter growth. While Zeo Scientifix Inc 's Revenue growth quarter on quarter, overall rank is 158.


Zeo Scientifix Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Apr 30 2026)		 12 Months Ending
(Jan 31 2026)		 12 Months Ending
(Oct 31 2025)		 12 Months Ending
(Jul 31 2025)		 12 Months Ending
(Apr 30 2025)
Cumulative Revenue 12 Months Ending $ 6.99 $ 5.56 $ 5.20 $ 4.79 $ 4.57
Y / Y Revenue Growth (TTM) 52.75 % 21.93 % 12.53 % -0.19 % -7.18 %
Year on Year Revenue Growth Overall Ranking # 3079 # 2393 # 2065 # 1602 # 2283
Seqeuential Revenue Change (TTM) 25.78 % 6.85 % 8.56 % 4.7 % 0.4 %
Seq. Revenue Growth (TTM) Overall Ranking # 2580 # 2358 # 2498 # 2349 # 1435


Cumulative Revenue growth Comment
Although Zeo Scientifix Inc 's Annual Revenue growth year on year were below company's average 85.8% , Revenue announced in the Apr 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 52.75% year on year, from 21.93% in Jan 31 2026.

In the Healthcare sector 418 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2393 to 3079.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 40
Healthcare Sector # 419
Overall # 3079

Revenue TTM Y/Y Growth Statistics
High Average Low
935.55 %
 85.8 %
-59.23 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 40
Sector # 373
S&P 500 # 2580
Cumulative Revenue growth Comment
Although Zeo Scientifix Inc 's Annual Revenue growth year on year were below company's average 85.8% , Revenue announced in the Apr 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 52.75% year on year, from 21.93% in Jan 31 2026.

In the Healthcare sector 418 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2393 to 3079.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 40
Healthcare Sector # 419
Overall # 3079

Revenue TTM Y/Y Growth Statistics
High Average Low
935.55 %
85.8 %
-59.23 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 40
Sector # 373
S&P 500 # 2580




Other Revenue Growth
Biotechnology & Pharmaceuticals Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
BPSR's Revenue Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue jump for the quarter ending Apr 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Apr 30 2026
Zeo Scientifix Inc 124.63%$ 124.630 millions
Kestra Medical Technologies Ltd 66.18%$ 66.181 millions


About Zeo Scientifix Inc Revenue Growth Rates (BPSR), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Zeo Scientifix Inc (CIK 1557376).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001829126-26-006486
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Zeo Scientifix Inc ’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.